9/11: The Big Cover Up

GUARDIAN– Six years after 9/11, the American public have still not been provided with a full and truthful account of the single greatest terror attack in US history.

What they got was a turkey. The 9/11 Commission was hamstrung by official obstruction. It never managed to ascertain the whole truth of what happened on September 11 2001.

The chair and vice chair of the 9/11 Commission, respectively Thomas Kean and Lee Hamilton, assert in their book, Without Precedent, that they were “set up to fail” and were starved of funds to do a proper investigation. They also confirm that they were denied access to the truth and misled by senior officials in the Pentagon and the federal aviation authority; and that this obstruction and deception led them to contemplate slapping officials with criminal charges.

Despite the many public statements by 9/11 commissioners and staff members acknowledging they were repeatedly lied to, not a single person has ever been charged, tried, or even reprimanded, for lying to the 9/11 Commission.

From the outset, the commission seemed to be hobbled. It did not start work until over a year after the attacks. Even then, its terms of reference were suspiciously narrow, its powers of investigation curiously limited and its time-frame for producing a report unhelpfully short – barely a year to sift through millions of pages of evidence and to interview hundreds of key witnesses.

The final report did not examine key evidence, and neglected serious anomalies in the various accounts of what happened. The commissioners admit their report was incomplete and flawed, and that many questions about the terror attacks remain unanswered. Nevertheless, the 9/11 Commission was swiftly closed down on August 21 2004.

I do not believe in conspiracy theories. I prefer rigorous, evidence-based analysis that sifts through the known facts and utilizes expert opinion to draw conclusions that stand up to critical scrutiny. In other words, I believe in everything the 9/11 Commission was not.

Continue reading full article about 9/11- The Big Cover Up.

© 2007 GUARDIAN

Photo by flickr user Cliff1066

Drug Firms Drove Swine Flu Pandemic Warning to Recoup Billions

DAILY MAIL– Drug companies manipulated the World Health Organisation into downgrading its definition of a pandemic so they could cash in on a swine flu outbreak, it is claimed.

An inquiry heard yesterday that the WHO allegedly softened its criteria for declaring a H1N1 flu pandemic last spring – just weeks before announcing there was a worldwide outbreak. Critics said the decision was driven by pharmaceutical companies desperate to recoup the billions of pounds they had invested in researching and developing pandemic vaccines after the bird flu scares in 2006 and 2007.

As a result, millions of people have been vaccinated against a mild illness, and money that could have been used to prevent and treat major killers such as heart disease has been squandered. The claims, which emerged during the first of several Council of Europe hearings into the handling of the swine flu pandemic, were strongly rejected by the WHO.

Following the organisation’s declaration of a pandemic, the Department of Health warned of 65,000 deaths, set up a special advice line and website, and suspended normal rules so anti-flu drugs could be given without prescription.

But with just 250 or so deaths in Britain and 14,000 worldwide, the WHO is being asked to account for its actions. The Government is now trying to off-load millions of jabs it ordered at the height of the scare. Sources say it is even considering giving some doses away for free.

Wolfgang Wodarg, former head of health at the Council of Europe, the Strasbourg-based ‘senate’ responsible for the European Court of Human Rights, said vaccine contracts were put in place in 2007, when it was feared the more lethal bird flu virus would mutate into human form.

Drug companies, which spent up to £2.5billion developing a vaccine, then pushed their interests within the WHO, leading to the definition of a pandemic being softened and an outbreak declared.

Continue reading about Drug Companies Driving Swine Flu.

© DAILY MAIL, 2010

Did World Health Organization Experts Fuel Swine Flu Scare?

TIMES OF INDIA– Even as questions are being raised about whether the swine flu scare was exaggerated to benefit pharma companies, evidence has surfaced that several members of the World Health Organization’s (WHO) vaccine board which pushed countries to buy the H1N1 vaccine have had significant ties with pharma companies.

This fact, which is bound to raise issues of conflict of interest, was exposed by Danish daily ‘Information’ last month. TOI attempted to get WHO’s response, but several emails sent to the office of the WHO director-general on January 9 met with no response.

Documents acquired through the Danish Freedom of Information Act revealed that Prof Juhani Eskola, a Finnish member of the WHO board on vaccines, ‘Strategic Advisory Group of Experts’ (SAGE), received almost 6.3 million euros in 2009 for his vaccine research programme, THL, from the vaccine manufacturers, GSK, qualifying GSK as THL’s main source of income. SAGE advises WHO chief Margaret Chan and recommends which vaccines and how much of it member countries should purchase, pointed out the Danish newspaper.

Apart from Prof Juhani Eskola, who received almost 6.3 million euros for his vaccine research programme, Danish journalists reported on six other members of ‘Strategic Advisory Group of Experts’ (SAGE) with financial ties to various pharmaceutical companies. These include Dr Peter Figueroa, Dr Neil Ferguson, Prof Malik Peiris, Dr Arnold Monto, Dr Friedrich Hayden and Dr Albert Osterhaus. Barring Dr Figuero, who revealed that he had accepted a research grant from Merck, none of the others made any disclosures.

Many of the pharmaceutical companies with which the vaccine board members had ties, are also the manufacturers of vaccines including the H1N1 vaccine like GlaxoSmithKline (GSK), Novartis, Solvay, Baxter, MedImmune and Sanofi Aventis. None of the WHO members on the vaccine board, barring one, declared any conflict of interest despite having extensive financial ties with the pharmaceutical companies in the form of research grants and consultancies.

In a statement issued on December 3, 2009, WHO claims that numerous safeguards are in place to manage possible conflicts of interest or their perception. “Members of SAGE are required to declare all professional and financial interests, including funding received from pharmaceutical companies or consultancies or other forms of professional engagement with pharmaceutical companies.

The names and affiliations of members of SAGE and of SAGE working groups are published on the WHO web site, together with meeting reports and declarations of interest submitted by the experts. Allegations of undeclared conflicts of interest are taken very seriously by WHO, and are immediately investigated,” says the statement. However, there is no such disclosure by these SAGE members on the WHO website.

© TIMES OF INDIA, 2010

Photo by flickr user Y

Obama’s ’05 Stock Investments- Conflict of Interest?

NY TIMES–  Less than two months after ascending to the United States Senate, Barack Obama bought more than $50,000 worth of stock in two speculative companies whose major investors included some of his biggest political donors.

One of the companies was a biotech concern that was starting to develop a drug to treat avian flu. In March 2005, two weeks after buying about $5,000 of its shares, Mr. Obama took the lead in a legislative push for more federal spending to battle the disease.

The most recent financial disclosure form for Mr. Obama, an Illinois Democrat, also shows that he bought more than $50,000 in stock in a satellite communications business whose principal backers include four friends and donors who had raised more than $150,000 for his political committees.

A spokesman for Mr. Obama, who is seeking his party’s presidential nomination in 2008, said yesterday that the senator did not know that he had invested in either company until fall 2005, when he learned of it and decided to sell the stocks. He sold them at a net loss of $13,000.

Read more about Obama’s ’05 Stock Investments- Conflict of Interest?

© 2007 NY TIMES

CNN Poll- 52% Say Obama Shouldn’t Be Re-elected

THE HILL– 52 percent of Americans said President Barack Obama doesn’t deserve reelection in 2012, according to a new poll.

44 percent of all Americans said they would vote to reelect the president in two and a half years, less than the slight majority who said they would prefer to elect someone else.

Obama faces a 44-52 deficit among both all Americans and registered voters, according to a CNN/Opinion Research poll released Tuesday. Four percent had no opinion.

The reelection numbers are slightly more sour than Obama’s approval ratings, which are basically tied. 49 percent of people told CNN that they approve of the way Obama is handling his job, while 50 percent disapprove.

Still, the 2012 election is still a long way’s away, with this fall’s midterm elections looming large. Republicans are hoping to make inroads into Congress, while Democrats are hoping to hold onto gains won in the 2006 and 2008 cycles.

Respondents to CNN were split at 46 percent as to whether they preferred a generic Republican or Democratic candidate in this fall’s elections.

At least one retiring lawmaker is confident Obama will sail to reelection, with Sen. Chris Dodd (D-Conn.) predicting Monday the president would win “overwhelmingly” in 2012.

The CNN poll, conducted Feb. 12-15, has a three percent margin of error.

© COPYRIGHT THE HILL, 2010

Photo by Flickr user US Army